Skip to main content
Erschienen in: The Journal of Obstetrics and Gynecology of India 4/2016

29.04.2016 | Short Commentary

Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles

verfasst von: Shilpa Saple, Mukesh Agrawal, Simi Kawar

Erschienen in: The Journal of Obstetrics and Gynecology of India | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Antagonist cycles have an inherent issue of lack of flexibility. As a result where batching of cycles is desired, it is not the preferred protocol in ART cycles. There is also the limitation of ovarian response in antagonist cycle due to the size heterogenesities of antral follicles at the start of stimulation. Among the different options available, use of estrogen in the luteal phase of the preceding cycle has definitely shown benefits with regard to better control of cycle as well as synchronization of follicles available for stimulation. The article gives a detailed analysis of the different options available for timing the egg collection in antagonist cycles, the advantages and drawbacks, and the method of use of estrogen. Whereas in the majority of the trials where estrogen pretreatment was used, the goal of scheduling of egg collection was definitely achieved, increased duration and dose of gonadotropin stimulation were required. There was definite advantage of higher oocyte yield in these cycles. The possibility of premature LH rise later during stimulation and subsequent poor implantation in these cycles has to be further evaluated. Nevertheless, batching of patient friendly antagonist cycles can be effectively possible by use of precycle estrogen treatment.
Literatur
1.
Zurück zum Zitat Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12(6):651–71.CrossRefPubMed Kolibianakis EM, Collins J, Tarlatzis BC, et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update. 2006;12(6):651–71.CrossRefPubMed
2.
Zurück zum Zitat Fauser BC, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist co- treatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril. 2005;83:1607–11.CrossRefPubMed Fauser BC, Devroey P. Why is the clinical acceptance of gonadotropin-releasing hormone antagonist co- treatment during ovarian hyperstimulation for in vitro fertilization so slow? Fertil Steril. 2005;83:1607–11.CrossRefPubMed
3.
Zurück zum Zitat de Klerk C, Macklon NS, Heijnen EM, et al. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod. 2007;22(2554):2558. de Klerk C, Macklon NS, Heijnen EM, et al. The psychological impact of IVF failure after two or more cycles of IVF with a mild versus standard treatment strategy. Hum Reprod. 2007;22(2554):2558.
4.
Zurück zum Zitat Domar AD, Smith Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. 2010;94:145799.CrossRef Domar AD, Smith Alper M. A prospective investigation into the reasons why insured United States patients drop out of in vitro fertilization treatment. Fertil Steril. 2010;94:145799.CrossRef
5.
Zurück zum Zitat Schroder AK, Katalinic A, Diedrich K, et al. Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online. 2004;8:600–6.CrossRefPubMed Schroder AK, Katalinic A, Diedrich K, et al. Cumulative pregnancy rates and drop-out rates in a German IVF programme: 4102 cycles in 2130 patients. Reprod Biomed Online. 2004;8:600–6.CrossRefPubMed
6.
Zurück zum Zitat Verberg MF, Eijkemans MJ, Heijnen EM, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050–5.CrossRefPubMed Verberg MF, Eijkemans MJ, Heijnen EM, et al. Why do couples drop-out from IVF treatment? A prospective cohort study. Hum Reprod. 2008;23:2050–5.CrossRefPubMed
8.
Zurück zum Zitat Franco JG Jr, Baruffi RL, Mauri AL, et al. GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis. Reprod Biomed Online. 2006;13(5):618–27.CrossRefPubMed Franco JG Jr, Baruffi RL, Mauri AL, et al. GnRH agonist versus GnRH antagonist in poor ovarian responders: a meta-analysis. Reprod Biomed Online. 2006;13(5):618–27.CrossRefPubMed
9.
Zurück zum Zitat Nikolettos N, Al-Hasani S, Felberbaum R, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol. 2001;97:202–7.CrossRefPubMed Nikolettos N, Al-Hasani S, Felberbaum R, et al. Gonadotropin-releasing hormone antagonist protocol: a novel method of ovarian stimulation in poor responders. Eur J Obstet Gynecol Reprod Biol. 2001;97:202–7.CrossRefPubMed
10.
Zurück zum Zitat Barmat LI, Chantilis SJ, Hurst BS, et al. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril. 2005;83(2):321–30.CrossRefPubMed Barmat LI, Chantilis SJ, Hurst BS, et al. A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization. Fertil Steril. 2005;83(2):321–30.CrossRefPubMed
11.
Zurück zum Zitat Griesinger G, Venetis CA, Marx T, et al. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008;90:197–204.CrossRef Griesinger G, Venetis CA, Marx T, et al. Oral contraceptive pill pretreatment in ovarian stimulation with GnRH antagonists for IVF: a systematic review and meta-analysis. Fertil Steril. 2008;90:197–204.CrossRef
12.
Zurück zum Zitat Dragesic KG, Davis OK, Fastouliotis SJ, et al. Use of a luteal estradiol patch and a gonadotropin- releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril. 2005;84:1023–6.CrossRef Dragesic KG, Davis OK, Fastouliotis SJ, et al. Use of a luteal estradiol patch and a gonadotropin- releasing hormone antagonist suppression protocol before gonadotropin stimulation for in vitro fertilization in poor responders. Fertil Steril. 2005;84:1023–6.CrossRef
13.
Zurück zum Zitat Elassar A, Mann JS, Engmann L, et al. Luteal phase estradiol verses luteal phase estradiol and antagonist protocol for controlled ovrian stimulation before in vitro fertilization in poor responders. Fertil Steril. 2011;95(1):324–6.CrossRefPubMed Elassar A, Mann JS, Engmann L, et al. Luteal phase estradiol verses luteal phase estradiol and antagonist protocol for controlled ovrian stimulation before in vitro fertilization in poor responders. Fertil Steril. 2011;95(1):324–6.CrossRefPubMed
14.
Zurück zum Zitat Kolibianakis EM, Bourgain C, Papanikolaou EG, et al. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod. 2005;20(9):2453–6.CrossRefPubMed Kolibianakis EM, Bourgain C, Papanikolaou EG, et al. Prolongation of follicular phase by delaying hCG administration results in a higher incidence of endometrial advancement on the day of oocyte retrieval in GnRH antagonist cycles. Hum Reprod. 2005;20(9):2453–6.CrossRefPubMed
15.
Zurück zum Zitat Tremellen KP, Lane M. Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod. 2010;25(5):1219–24.CrossRefPubMed Tremellen KP, Lane M. Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. Hum Reprod. 2010;25(5):1219–24.CrossRefPubMed
16.
Zurück zum Zitat Roseff SJ, Bangah ML, Kettel LM, et al. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab. 1989;69(5):1033–9.CrossRefPubMed Roseff SJ, Bangah ML, Kettel LM, et al. Dynamic changes in circulating inhibin levels during the luteal-follicular transition of the human menstrual cycle. J Clin Endocrinol Metab. 1989;69(5):1033–9.CrossRefPubMed
17.
Zurück zum Zitat de Ziegler D, Jääskeläinen AS, Brioschi A, et al. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod. 1998;13(3):561–4.CrossRefPubMed de Ziegler D, Jääskeläinen AS, Brioschi A, et al. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod. 1998;13(3):561–4.CrossRefPubMed
18.
Zurück zum Zitat Zeleznik AJ, Hutchison JS, Schuler HM. Interference with the gonadotropin-suppressing actions of estradiol in macaques overrides the selection of a single preovulatory follicle. Endocrinology. 1985;117(3):991–9.CrossRefPubMed Zeleznik AJ, Hutchison JS, Schuler HM. Interference with the gonadotropin-suppressing actions of estradiol in macaques overrides the selection of a single preovulatory follicle. Endocrinology. 1985;117(3):991–9.CrossRefPubMed
19.
Zurück zum Zitat Lahlou N, Chabbert-Buffet N, Christin-Maitre S, et al. Main inhibitor of follicle stimulating hormone in the luteal–follicular transition: inhibin A, oestradiol, or inhibin B? Hum Reprod. 1999;14(5):1190–3.CrossRefPubMed Lahlou N, Chabbert-Buffet N, Christin-Maitre S, et al. Main inhibitor of follicle stimulating hormone in the luteal–follicular transition: inhibin A, oestradiol, or inhibin B? Hum Reprod. 1999;14(5):1190–3.CrossRefPubMed
20.
Zurück zum Zitat Lelaidier C, de Ziegler D, Gaetano J, et al. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophinreleasing hormone agonist. Hum Reprod. 1992;7:1353–6.PubMed Lelaidier C, de Ziegler D, Gaetano J, et al. Controlled preparation of the endometrium with exogenous oestradiol and progesterone: a novel regimen not using a gonadotrophinreleasing hormone agonist. Hum Reprod. 1992;7:1353–6.PubMed
21.
Zurück zum Zitat Fanchin R, Salomon L, Castelo-Branco A, et al. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod. 2003;18(12):2698–703.CrossRefPubMed Fanchin R, Salomon L, Castelo-Branco A, et al. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod. 2003;18(12):2698–703.CrossRefPubMed
22.
Zurück zum Zitat Blockeel C, Engels S, De Vos M, et al. Oestradiol valerate pretreatment in GnRH –antagonist cycles: a randomized controlled trial. Reprod Biomed Online. 2012;24:272–80.CrossRefPubMed Blockeel C, Engels S, De Vos M, et al. Oestradiol valerate pretreatment in GnRH –antagonist cycles: a randomized controlled trial. Reprod Biomed Online. 2012;24:272–80.CrossRefPubMed
23.
Zurück zum Zitat Hauzman EE, Zapata A, Bermejo A, et al. Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial. Reprod Biol Endocrinol. 2013;11:96.CrossRefPubMedPubMedCentral Hauzman EE, Zapata A, Bermejo A, et al. Cycle scheduling for in vitro fertilization with oral contraceptive pills versus oral estradiol valerate: a randomized, controlled trial. Reprod Biol Endocrinol. 2013;11:96.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Ye H, Huang GN, Zeng PH, et al. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-tretment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomised study. J Assit Reprod Genet. 2009;26:105–11.CrossRef Ye H, Huang GN, Zeng PH, et al. IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-tretment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomised study. J Assit Reprod Genet. 2009;26:105–11.CrossRef
25.
Zurück zum Zitat Cédrin-Durnerin I, Guivarc’h-Leveque A, Hugues JN. Pretreatment with estrogen does not affect IVF/ICSI outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomised trial. Fertil Steril. 2012;97(6):1359–64.CrossRefPubMed Cédrin-Durnerin I, Guivarc’h-Leveque A, Hugues JN. Pretreatment with estrogen does not affect IVF/ICSI outcome compared with no pretreatment in GnRH antagonist protocol: a prospective randomised trial. Fertil Steril. 2012;97(6):1359–64.CrossRefPubMed
26.
Zurück zum Zitat Chang EM, Han JE, Won HJ, et al. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vito fertilization. J Assit Reprod Genet. 2012;29:225–30.CrossRef Chang EM, Han JE, Won HJ, et al. Effect of estrogen priming through luteal phase and stimulation phase in poor responders in in-vito fertilization. J Assit Reprod Genet. 2012;29:225–30.CrossRef
27.
Zurück zum Zitat Cédrin-Durnerin I, Bständig B, Parneix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22(1):109–16.CrossRefPubMed Cédrin-Durnerin I, Bständig B, Parneix I, et al. Effects of oral contraceptive, synthetic progestogen or natural estrogen pre-treatments on the hormonal profile and the antral follicle cohort before GnRH antagonist protocol. Hum Reprod. 2007;22(1):109–16.CrossRefPubMed
28.
Zurück zum Zitat Frattarelli JL, Hill MJ, McWilliams GD, et al. A luteal estradiol protocol for expected poor responders improves embryo number and quality. Fertil Steril. 2008;89:1118–11222.CrossRefPubMed Frattarelli JL, Hill MJ, McWilliams GD, et al. A luteal estradiol protocol for expected poor responders improves embryo number and quality. Fertil Steril. 2008;89:1118–11222.CrossRefPubMed
Metadaten
Titel
Precycle Estradiol in Synchronization and Scheduling of Antagonist Cycles
verfasst von
Shilpa Saple
Mukesh Agrawal
Simi Kawar
Publikationsdatum
29.04.2016
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India / Ausgabe 4/2016
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-016-0877-z

Weitere Artikel der Ausgabe 4/2016

The Journal of Obstetrics and Gynecology of India 4/2016 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.